Description
CelProtect contains a unique combination of chemo-preventive polyphenols that promote antitumor immune activity. CelProtect provides anti-oxidant, anti-cancer and is a potent inhibitor of angiogenesis - a critical function for tumour survival.
| Ingredients |
|---|
| Pueraria lobata (root) (contains: Daidzein) |
| Glycine max (seed) (contains: Glycitein and Genistein) |
| Scutellariae baicalensis (root) (contains: Baicalein and Baicalin) |
| Gardenia jasminoides (fruit) |
Other Ingredients: Vegetable cellulose (hypromellose); Vegetable Stearic Acid; Microcrystalline Cellulose and Vegetable Magnesium Stearate.
Does Not Contain: Wheat, gluten, milk, eggs, fish, crustacean shellfish, tree nuts, peanuts
Actions
• Anti-inflammatory
• Enhances immunologic functions
• Inhibits angiogenesis
• Anti-tumoural
Indications
• Inflammatory conditionsI
• Immunologic deficiencies
• Prostate cancer
• Breast cancer
• Colon cancer
• kin cancerS
• Renal cell carcinoma
• Lymphoma
Suggested Use:
2 to 5 caps 1 to 2 times daily
Caution:
If the Gleason grade is above 2 and the total score is greater than 6, Genistein (CelProtect) is only to be used with radio and/or chemotherapy. CelProtect may enhance these treatments. Below these levels CelProtect is the recommended protocol and hormone therapy is NOT recommended.
Warning:
Contraindicated in pregnancy and breast-feeding. May be contraindicated with estrogen dependant breast cancer depending on dosage.
CelProtect may potentiate the effect of hypoglycemic medications and insulin and could lead to enhanced drug effects and hypoglycaemia.
Diabetes Type 1 - potential to interfere with insulin
Diabetes Type 2- potential to interfere with hypoglycaemic drugs / and insulin
Prescribe cautiously and monitor blood sugar regularly. The patient needs to be warned about the potential hypoglycemic effects and their medication may need to be adjusted (reduced) as necessary in conjunction with their prescribing practitioner.